EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+12.6%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$204M
AUM Growth
+$204M
(+2.9%)
Cap. Flow
-$7.51M
Cap. Flow
% of AUM
-3.68%
Top 10 Holdings %
Top 10 Hldgs %
56.57%
Holding
75
New
19
Increased
12
Reduced
25
Closed
6
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$5.29M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$3.97M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$3.6M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$3.04M |
| 5 |
Sanofi
SNY
|
$3M |
Top Sells
| 1 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$9.92M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$9.66M |
| 3 |
The Ensign Group
ENSG
|
$5.73M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$5.19M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$3.78M |
Sector Composition
| 1 | Healthcare | 59.7% |
| 2 | Real Estate | 12.16% |
| 3 | Industrials | 8.94% |
| 4 | Financials | 0.61% |
| 5 | Technology | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
26
DELISTED
Invacare Corporation
IVC
| $1.86M | 0.85% |
99,902
| – | – |
|
27
CareTrust REIT
CTRE
$7.53B
| $1.71M | 0.78% |
101,264
-7,000
| -6% | -$118K |
|
|
MDCO
28
DELISTED
Medicines Co
MDCO
| $1.44M | 0.66% |
39,317
| – | – |
|
|
CBAY
29
DELISTED
Cymabay Therapeutics
CBAY
| $1.44M | 0.66% |
+107,096
| New | +$1.44M |
|
|
AMRN
30
Amarin Corp
AMRN
$311M
| $1.42M | 0.65% |
460,000
+210,000
| +84% | +$649K |
|
31
Puma Biotechnology
PBYI
$258M
| $1.42M | 0.65% |
23,924
+1,000
| +4% | +$59.2K |
|
32
Tandem Diabetes Care
TNDM
$834M
| $1.35M | 0.62% |
+61,300
| New | +$1.35M |
|
33
Haemonetics
HAE
$2.57B
| $1.31M | 0.6% |
14,646
| – | – |
|
|
IMMU
34
DELISTED
Immunomedics Inc
IMMU
| $1.3M | 0.6% |
+55,000
| New | +$1.3M |
|
|
MYOK
35
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.29M | 0.59% |
25,950
-16,050
| -38% | -$797K |
|
36
Madrigal Pharmaceuticals
MDGL
$9.7B
| $1.26M | 0.58% |
+4,500
| New | +$1.26M |
|
37
eHealth
EHTH
$126M
| $1.25M | 0.57% |
56,546
-18,000
| -24% | -$398K |
|
38
Elevance Health
ELV
$72.4B
| $1.19M | 0.54% |
5,000
-1,000
| -17% | -$238K |
|
|
AKRX
39
DELISTED
Akorn, Inc.
AKRX
| $1.16M | 0.53% |
+70,000
| New | +$1.16M |
|
40
TG Therapeutics
TGTX
$5.03B
| $1.05M | 0.48% |
80,000
-70,000
| -47% | -$921K |
|
|
DRNA
41
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.04M | 0.48% |
+85,000
| New | +$1.04M |
|
42
Centene
CNC
$14.8B
| $986K | 0.45% |
8,000
-2,000
| -20% | -$246K |
|
43
BioCryst Pharmaceuticals
BCRX
$1.74B
| $854K | 0.39% |
148,959
| – | – |
|
|
CLLS
44
Cellectis
CLLS
$260M
| $849K | 0.39% |
+30,000
| New | +$849K |
|
|
ARRY
45
DELISTED
Array Biopharma Inc
ARRY
| $812K | 0.37% |
48,412
-309,315
| -86% | -$5.19M |
|
46
Vericel Corp
VCEL
$1.69B
| $726K | 0.33% |
+74,837
| New | +$726K |
|
47
Arbutus Biopharma
ABUS
$753M
| $712K | 0.33% |
97,495
-20,000
| -17% | -$146K |
|
48
Iovance Biotherapeutics
IOVA
$800M
| $704K | 0.32% |
55,000
-10,000
| -15% | -$128K |
|
|
EPZM
49
DELISTED
Epizyme, Inc
EPZM
| $643K | 0.29% |
47,449
-10,000
| -17% | -$136K |
|
|
ALBO
50
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $640K | 0.29% |
18,029
| – | – |
|